Exploring the Potential of Artificial Intelligence and Machine Learning to Combat COVID-19 and Existing Opportunities for LMIC: A Scoping Review
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: In the face of the current time-sensitive COVID-19 pandemic, the limited capacity of healthcare systems resulted in an emerging need to develop newer methods to control the spread of the pandemic. Artificial Intelligence (AI), and Machine Learning (ML) have a vast potential to exponentially optimize health care research. The use of AI-driven tools in LMIC can help in eradicating health inequalities and decrease the burden on health systems. Methods: The literature search for this Scoping review was conducted through the PubMed database using keywords: COVID-19, Artificial Intelligence (AI), Machine Learning (ML), and Low Middle-Income Countries (LMIC). Forty-three articles were identified and screened for eligibility and 13 were included in the final review. All the items of this Scoping review are reported using guidelines for PRISMA extension for scoping reviews (PRISMA-ScR). Results: Results were synthesized and reported under 4 themes. (a) The need of AI during this pandemic: AI can assist to increase the speed and accuracy of identification of cases and through data mining to deal with the health crisis efficiently, (b) Utility of AI in COVID-19 screening, contact tracing, and diagnosis: Efficacy for virus detection can a be increased by deploying the smart city data network using terminal tracking system along-with prediction of future outbreaks, (c) Use of AI in COVID-19 patient monitoring and drug development: A Deep learning system provides valuable information regarding protein structures associated with COVID-19 which could be utilized for vaccine formulation, and (d) AI beyond COVID-19 and opportunities for Low-Middle Income Countries (LMIC): There is a lack of financial, material, and human resources in LMIC, AI can minimize the workload on human labor and help in analyzing vast medical data, potentiating predictive and preventive healthcare. Conclusion: AI-based tools can be a game-changer for diagnosis, treatment, and management of COVID-19 patients with the potential to reshape the future of healthcare in LMIC.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and Explanation
Tricco, A. C., Lillie, E., Zarin, W., O'Brien, K. K., Colquhoun, H., Levac, D., Moher, D., Peters, M. D. J., Horsley, T., Weeks, L., et al. (2018) · Annals of Internal Medicine · doi:10.7326/m18-0850 · Cited by 43,565
Li, L., Qin, L., Xu, Z., Yin, Y., Wang, X., Kong, B., Bai, J., Lu, Y., Fang, Z., Song, Q., et al. (2020) · Radiology · doi:10.1148/radiol.2020200905 · Cited by 1,927 · cited 3×
“15,25 AI-driven AI-driven tools can detect tiny features in radiology data (pixel-level nodules) and AI-empowered image segmentation can perform accurate and efficient diagnosis and analysis, which may not be picked up by radiologists.”
BackgroundDigital technology and COVID-19
Ting, D. S. W., Carin, L., Dzau, V., & Wong, T. Y. (2020) · Nature Medicine · doi:10.1038/s41591-020-0824-5 · Cited by 1,413
Shi, F., Wang, J., Shi, J., Wu, Z., Wang, Q., Tang, Z., He, K., Shi, Y., & Shen, D. (2021) · IEEE Reviews in Biomedical Engineering · doi:10.1109/rbme.2020.2987975 · Cited by 1,404 · cited 4×
“18,21,24 For instance, the average processing time for a trained deep learning algorithm to identify COVID-19 on CT chest was 4.51 seconds, as compared to an average of 10 minutes 9 seconds required by a radiologist.”
BackgroundMethodInfluentialBini, S. A. (2018) · The Journal of Arthroplasty · doi:10.1016/j.arth.2018.02.067 · Cited by 670 · cited 2×
“3,4 Deep learning, a subset of ML, uses neural networks, which are one of the most beautiful programming paradigms ever invented (Figure 1).”
BackgroundAlami, H., Rivard, L., Lehoux, P., Hoffman, S. J., Cadeddu, S. B. M., Savoldelli, M., Samri, M. A., Ag Ahmed, M. A., Fleet, R., & Fortin, J.-P. (2020) · Globalization and Health · doi:10.1186/s12992-020-00584-1 · Cited by 283
Husnayain, A., Fuad, A., & Su, E. C.-Y. (2020) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2020.03.021 · Cited by 249
Cited by
Coronavirus disease (COVID-19) cases analysis using machine-learning applications
Kwekha-Rashid, A. S., Abduljabbar, H. N., & Alhayani, B. (2023) · Applied Nanoscience · doi:10.1007/s13204-021-01868-7 · Cited by 348
Kansal, R., Bawa, A., Bansal, A., Trehan, S., Goyal, K., Goyal, N., & Malhotra, K. (2022) · Cureus · doi:10.7759/cureus.21434 · Cited by 76
“Furthermore, AI-based tools may help improve the healthcare systems in lower middle-income countries [12,13].”
BackgroundSuccess stories of AI in drug discovery - where do things stand?
Mak, K.-K., Balijepalli, M. K., & Pichika, M. R. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2022.1985108 · Cited by 51
Khan, S. D., Hoodbhoy, Z., Raja, M. H. R., Kim, J. Y., Hogg, H. D. J., Manji, A. A. A., Gulamali, F., Hasan, A., Shaikh, A., Tajuddin, S., et al. (2024) · PLOS Digital Health · doi:10.1371/journal.pdig.0000514 · Cited by 36
Metadata
- Authors
- Naseem, M., Akhund, R., Arshad, H., & Ibrahim, M. T.
- Venue
- Journal of Primary Care & Community Health
- Publisher
- SAGE Publications
- Published
- 2020-01
- Volume
- 11
- Pages
- 2150132720963634-2150132720963634
- ISSN
- 2150-1319 (ISSN-L)
- 2150-1327
- OpenAlex
- W3089552093
- Cited by
- 105
- References
- 7
- FWCI
- 4.53
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.